Ma. Subramanian, State Minister for Health, unveiling the new logo of REACH during the 25th anniversary celebrations of the NGO held in Chennai on Friday. Looking on are (from left) Ramya Ananthakrishnan, director, REACH, Nalini Krishnan, executive secretary & co-founder, REACH, Soumya Swaminathan, former chief scientist, WHO, Sivamurugan, REACH executive committee, and N. Ram, Director, … Read more
Speaking in a panel discussion as part of BioAsia 2022, she said though several high-end countries have completed vaccination to the extent of 90 per cent some of the nations in Africa have completed only 10 per cent inoculation even as there was ease on vaccine supply side globally. Though the scientific achievement with regards … Read more
Swaminathan’s concerns come amidst the worrying possibility of COVID’s third wave in India (Photo: Reuters) World Health Organisation Chief Scientist Soumya Swaminathan on Wednesday said the world needs to step up its vaccination drive and ensure maximum coverage. This comes following alarming trends from Europe. Swaminathan took to microblogging site Twitter and noted that there … Read more
World Health Organisation Chief Scientist Soumya Swaminathan World Health Organisation (WHO) chief scientist Soumya Swaminathan on Thursday warned that the next pandemic was not an “if” but a “when”, and it could be waiting to happen anytime. The pandemic has shown that a health security threat can be as bad as any other kind of … Read more
WHO chief scientist Swaminathan said, Covid-19 will exist with ups and downs Covid-19 Pandemic Endemicity Phase: As the healthcare authorities ready hospitals for an impending Covid-19 third wave, Chief Scientist of the World Health Organisation Dr. Soumya Swaminathan giving some ray of hope said that India might be entering some kind of stage of ‘endemicity’. … Read more
The target at present is to vaccinate at least 10% of the vulnerable in every country by September. Soumya Swaminathan, a scientist at the World Health Organisation (WHO), has urged countries to explore options for increasing vaccine production, including voluntary licences, technology pools, use of TRIPS flexibilities and waiver of intellectual property provisions. Countries would … Read more